Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

2011582 citationsJournal Articlegreen Open Access

Authors

Jan Franko

Qian Shi · Mayo Clinic in Arizona

Daniel J. Sargent · University of North Carolina at Chapel Hill

Abstract

pcCRC is associated with a significantly shorter OS and PFS as compared with other manifestations of mCRC. Future trials for mCRC should consider stratifying on the basis of pcCRC status.

Topics & Keywords

Intraperitoneal and Appendiceal Malignancies Hepatocellular Carcinoma Treatment and Prognosis Colorectal Cancer Treatments and Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 30, Issue 3, pp. 263-267

DOI: 10.1200/jco.2011.37.1039

Field-Weighted Citation Impact: 28.29